776 related articles for article (PubMed ID: 12764551)
21. Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
Del Sole A; Clerici F; Chiti A; Lecchi M; Mariani C; Maggiore L; Mosconi L; Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1357-66. PubMed ID: 18418593
[TBL] [Abstract][Full Text] [Related]
22. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
Sörensen A; Blazhenets G; Rücker G; Schiller F; Meyer PT; Frings L;
Neuroimage Clin; 2019; 21():101637. PubMed ID: 30553760
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.
Fouquet M; Desgranges B; Landeau B; Duchesnay E; Mézenge F; de la Sayette V; Viader F; Baron JC; Eustache F; Chételat G
Brain; 2009 Aug; 132(Pt 8):2058-67. PubMed ID: 19477964
[TBL] [Abstract][Full Text] [Related]
25. Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
Habeck C; Risacher S; Lee GJ; Glymour MM; Mormino E; Mukherjee S; Kim S; Nho K; DeCarli C; Saykin AJ; Crane PK;
Brain Imaging Behav; 2012 Dec; 6(4):568-83. PubMed ID: 23179062
[TBL] [Abstract][Full Text] [Related]
26. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
[TBL] [Abstract][Full Text] [Related]
28. Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.
Bensamoun D; Guignard R; Furst AJ; Derreumaux A; Manera V; Darcourt J; Benoit M; Robert PH; David R
J Alzheimers Dis; 2016; 49(2):387-98. PubMed ID: 26484900
[TBL] [Abstract][Full Text] [Related]
29. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
Inui Y; Ito K; Kato T;
J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157
[TBL] [Abstract][Full Text] [Related]
30. MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings.
Pagani M; Dessi B; Morbelli S; Brugnolo A; Salmaso D; Piccini A; Mazzei D; Villavecchia G; Larsson SA; Rodriguez G; Nobili F
Curr Alzheimer Res; 2010 Jun; 7(4):287-94. PubMed ID: 19939228
[TBL] [Abstract][Full Text] [Related]
31. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
Borroni B; Anchisi D; Paghera B; Vicini B; Kerrouche N; Garibotto V; Terzi A; Vignolo LA; Di Luca M; Giubbini R; Padovani A; Perani D
Neurobiol Aging; 2006 Jan; 27(1):24-31. PubMed ID: 16298237
[TBL] [Abstract][Full Text] [Related]
32. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
[TBL] [Abstract][Full Text] [Related]
33. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Langbaum JB; Chen K; Lee W; Reschke C; Bandy D; Fleisher AS; Alexander GE; Foster NL; Weiner MW; Koeppe RA; Jagust WJ; Reiman EM;
Neuroimage; 2009 May; 45(4):1107-16. PubMed ID: 19349228
[TBL] [Abstract][Full Text] [Related]
34. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
35. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.
Chen K; Langbaum JB; Fleisher AS; Ayutyanont N; Reschke C; Lee W; Liu X; Bandy D; Alexander GE; Thompson PM; Foster NL; Harvey DJ; de Leon MJ; Koeppe RA; Jagust WJ; Weiner MW; Reiman EM;
Neuroimage; 2010 Jun; 51(2):654-64. PubMed ID: 20202480
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.
Chételat G; Eustache F; Viader F; De La Sayette V; Pélerin A; Mézenge F; Hannequin D; Dupuy B; Baron JC; Desgranges B
Neurocase; 2005 Feb; 11(1):14-25. PubMed ID: 15804920
[TBL] [Abstract][Full Text] [Related]
37. Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment.
Youn H; Lee ES; Lee S; Suh S; Jeong HG; Eo JS
J Affect Disord; 2018 Oct; 239():30-36. PubMed ID: 29991443
[TBL] [Abstract][Full Text] [Related]
38. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.
Arnáiz E; Jelic V; Almkvist O; Wahlund LO; Winblad B; Valind S; Nordberg A
Neuroreport; 2001 Mar; 12(4):851-5. PubMed ID: 11277595
[TBL] [Abstract][Full Text] [Related]
39. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
[TBL] [Abstract][Full Text] [Related]
40. Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment.
Perneczky R; Hartmann J; Grimmer T; Drzezga A; Kurz A
J Geriatr Psychiatry Neurol; 2007 Jun; 20(2):84-8. PubMed ID: 17548777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
